Exane Derivatives Alector, Inc. Transaction History

Exane Derivatives

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$7.65 - $14.24 $35,144 - $65,418	-4,594 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$13.02 - $20.78 $5,064 - $8,083	-389 Reduced 7.81%	4,594 $65,000
Q4 2021 Jan 28, 2022	BUY	$19.35 - $25.54 $94,157 - $124,277	4,866 Added 4158.97%	4,983 $102,000
Q2 2021 Jul 28, 2021	BUY	$15.5 - $22.48 $1,813 - $2,630	117 New	117 $2,000
Q1 2021 Apr 30, 2021	SELL	$14.84 - $22.23 $87,556 - $131,157	-5,900 Closed	0 $0
Q3 2020 Oct 06, 2020	BUY	$10.54 - $24.96 $62,185 - $147,264	5,900 New	5,900 $62,000

167

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $149M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.